iOnctura picks up Series A

iOnctura B.V., a Swiss clinical stage biopharmaceutical company, has raised 15 million euros in Series A financing.

iOnctura B.V., a Swiss clinical stage biopharmaceutical company, has raised 15 million euros in Series A financing. The investors were INKEF Capital, VI Partners, Schroder Adveq and M Ventures.

Source: Press Release